Patient characteristics
Characteristic . | Patients . |
|---|---|
| Median age, y (range) | 46 (22-59) |
| No. male/female | 28/18 |
| No. donors, matched family/unrelated | 32/14 |
| No. female donor/male recipient sex mismatches | 11 |
| Disease | |
| Myeloma | 19 |
| Hodgkin lymphoma | 13 |
| LG-NHL/CLL/PLL | 7/2/1 |
| HG-NHL | 3 |
| CML | 1 |
| GVHD prior to DLI | |
| Related donor, grade I/II | 3/1 |
| Unrelated donor, grade I/II | 3/1 |
Characteristic . | Patients . |
|---|---|
| Median age, y (range) | 46 (22-59) |
| No. male/female | 28/18 |
| No. donors, matched family/unrelated | 32/14 |
| No. female donor/male recipient sex mismatches | 11 |
| Disease | |
| Myeloma | 19 |
| Hodgkin lymphoma | 13 |
| LG-NHL/CLL/PLL | 7/2/1 |
| HG-NHL | 3 |
| CML | 1 |
| GVHD prior to DLI | |
| Related donor, grade I/II | 3/1 |
| Unrelated donor, grade I/II | 3/1 |
LG-NHL indicates low-grade non-Hodgkin lymphoma; CLL, chronic lymphocytic leukemia; PLL, prolymphocytic leukemia, HG-NHL, high-grade non-Hodgkin lymphoma; CML, chronic myeloid leukemia.